Strategic collaboration NeuroRPM has a recent partnership with Annovis Bio to implement an FDA-cleared AI platform for movement data in Parkinson's studies, presenting a cross-industry collaboration opportunity to expand data analytics, movement tracking, and digital health capabilities with biotechnology partners.

Clinical trial focus The company operates in clinical trials with multiple participating partners, indicating a need for scalable data analytics, remote monitoring, and secure data exchange solutions tailored to regulated health environments.

AI driven analytics NeuroRPM emphasizes AI and analytics for neurodegenerative care, suggesting sales potential for advanced data platforms, ML model hosting, privacy-compliant data pipelines, and integration with clinical workflows.

Cloud and web stack Leveraging AWS, Google Cloud CDN, and web/mobile technologies signals opportunities to upsell cloud-native services, performance optimization, content delivery, and mobile-ready data portals for clinicians and researchers.

Growth characteristics Small-to-mid sized team with revenue in the lower mid-range and ample growth potential presents a target for scalable deployment, managed services, and phased integration projects that align with budget-conscious health-tech buyers.